Senior insider sale
EVP, U.S. Commercial at TEVA PHARMACEUTICAL INDUSTRIES LTD — senior position signals high conviction
$1.32M
39.09K shares
What this filing means
FOX CHRISTINE plans to sell 39.09K shares of TEVA PHARMACEUTICAL INDUSTRIES LTD valued at approximately $1.32M. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 4/30/2026ACC: 0001628280-26-028956
Officer· EVP, U.S. Commercial
Since Mar 2026
39.09K
Shares to sell
$1.32M
Approx. market value
21.26K
Acquired (3 months)
1
Planned
2 completed
Securities Acquired — Last 3 Months2
Vesting of a Stock Award
Compensatory Payment
3/5/2026
9.89KVesting of a Stock Award
Compensatory Payment
3/4/2026
11.36KTotal acquired21.26K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
3/5/2026 | Vesting of a Stock Award Compensatory Payment | 9.89K | — |
3/4/2026 | Vesting of a Stock Award Compensatory Payment | 11.36K | — |
| Total | 21.26K | ||
Planned & Completed Dispositions3
Completed
—Completed
Units to sell
7.92K
Market value
$250.9K
3/5/2026
—Completed
Units to sell
9.91K
Market value
$321.7K
3/4/2026
Planned — Approximate Date
NYSEPlanned
Units to sell
21.26K
Market value
$750.6K
4/30/2026
Total
Units
39.09K
Value
$1.32M
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
3/5/2026 | 7.92K | $250.9K | — | Completed |
3/4/2026 | 9.91K | $321.7K | — | Completed |
| Planned — Approximate Date | ||||
4/30/2026 | 21.26K | $750.6K | NYSE | Planned |
| Total | 39.09K | $1.32M | ||